{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:21:09Z","timestamp":1770909669309,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST111-2628-B-038-025"],"award-info":[{"award-number":["MOST111-2628-B-038-025"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU111-5803-009-111"],"award-info":[{"award-number":["TMU111-5803-009-111"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU111-5812-001-400"],"award-info":[{"award-number":["TMU111-5812-001-400"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107D37-003-MY3-1"],"award-info":[{"award-number":["V107D37-003-MY3-1"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107D37-003-MY3-2"],"award-info":[{"award-number":["V107D37-003-MY3-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107D37-003-MY3-3"],"award-info":[{"award-number":["V107D37-003-MY3-3"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111342","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T11:31:59Z","timestamp":1702639919000},"page":"111342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dynamics of T-cell receptor repertoire in patients with ankylosing spondylitis after biologic therapy"],"prefix":"10.1016","volume":"127","author":[{"given":"Wei-Chih","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-9744","authenticated-orcid":false,"given":"Che-Mai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-4840","authenticated-orcid":false,"given":"Hsien-Tzung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-5924","authenticated-orcid":false,"given":"Wei-Chiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2023.111342_b0005","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/kei047","article-title":"The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis","volume":"44","author":"Zochling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.intimp.2023.111342_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-857X(21)00888-7","article-title":"Ankylosing spondylitis and other spondyloarthropathies","volume":"16","author":"Khan","year":"1990","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.intimp.2023.111342_b0015","article-title":"Ankylosing spondylitis: from cells to genes","author":"Zambrano-Zaragoza","year":"2013","journal-title":"Int. J. Inflam."},{"issue":"9","key":"10.1016\/j.intimp.2023.111342_b0020","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","article-title":"Pathogenesis of ankylosing spondylitis","volume":"6","author":"Tam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"26","key":"10.1016\/j.intimp.2023.111342_b0030","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing Spondylitis and Axial Spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.111342_b0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2014.00425","article-title":"Effects of Interleukin-17A on Osteogenic Differentiation of Isolated Human Mesenchymal Stem Cells","volume":"5","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111342_b0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","article-title":"IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis","volume":"20","author":"Jo","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2023.111342_b0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0055","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.111342_b0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3899\/jrheum.141001","article-title":"2014 Update of the Canadian Rheumatology Association\/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations","volume":"42","author":"Rohekar","year":"2015","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.111342_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/1756-185X.13752","article-title":"Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis","volume":"23","author":"Wei","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.111342_b0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2012-202533","article-title":"Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial","volume":"73","author":"Huang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2023.111342_b0085","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/rheumatology\/keu132","article-title":"Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial","volume":"53","author":"Bao","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.intimp.2023.111342_b0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3899\/jrheum.170487","article-title":"Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study","volume":"45","author":"Deodhar","year":"2018","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0095","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.23233","article-title":"Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study","volume":"69","author":"Marzo-Ortega","year":"2017","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.40753","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111342_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/1756-185X.13094","article-title":"Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies","volume":"20","author":"Wei","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2023.111342_b0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/annrheumdis-2020-219406","article-title":"Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial","volume":"80","author":"Wei","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.111342_b0115","first-page":"57","article-title":"Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects, Open Access","volume":"14","author":"Perrotta","year":"2022","journal-title":"Rheumatol"},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0120","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.40028","article-title":"Discovery of T Cell Receptor \u03b2 Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis","volume":"69","author":"Faham","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0125","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/rheumatology\/kex517","article-title":"CD8+ T cells with characteristic T cell receptor beta motif are detected in blood and expanded in synovial fluid of ankylosing spondylitis patients","volume":"57","author":"Komech","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.humimm.2018.03.007","article-title":"Characterization of peripheral blood TCR repertoire in patients with ankylosing spondylitis by high-throughput sequencing","volume":"79","author":"Cui","year":"2018","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0135","doi-asserted-by":"crossref","first-page":"e3000314","DOI":"10.1371\/journal.pbio.3000314","article-title":"Detecting T cell receptors involved in immune responses from single repertoire snapshots","volume":"17","author":"Pogorelyy","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.intimp.2023.111342_b0140","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ebiom.2019.07.032","article-title":"TCR repertoire and CDR3 motif analyses depict the role of \u03b1\u03b2 T cells in Ankylosing spondylitis","volume":"47","author":"Zheng","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.111342_b0145","doi-asserted-by":"crossref","unstructured":"A.L. Hanson, H.J. Nel, L. Bradbury, J. Phipps, R. Thomas, L.C. KA, T.J. Kenna, M.A. Brown, Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis Patients, Arthritis Rheumatol 72(8) (2020) 1289-1302.","DOI":"10.1002\/art.41252"},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ecco-jcc\/jjx012","article-title":"Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease","volume":"11","author":"Doorenspleet","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.intimp.2023.111342_b0155","doi-asserted-by":"crossref","first-page":"2364943","DOI":"10.1155\/2019\/2364943","article-title":"Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies","volume":"2019","author":"Chang","year":"2019","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A Proposal for Modification of the New York Criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.intimp.2023.111342_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0170","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1002\/ctm2.136","article-title":"Using T-cell repertoire profiles as predictor in a primary mucosal melanoma","volume":"10","author":"Chang","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0175","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10875-021-01045-z","article-title":"Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia","volume":"41","author":"Chang","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.111342_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.853403","article-title":"Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.111342_b0185","doi-asserted-by":"crossref","unstructured":"M. Martin, Cutadapt removes adapter sequences from high-throughput sequencing reads, 2011 17(1) (2011) 3.","DOI":"10.14806\/ej.17.1.200"},{"issue":"6","key":"10.1016\/j.intimp.2023.111342_b0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nmeth.2960","article-title":"Towards error-free profiling of immune repertoires","volume":"11","author":"Shugay","year":"2014","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.intimp.2023.111342_b0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.intimp.2023.111342_b0200","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1128\/JVI.03474-14","article-title":"Dynamics of the cytotoxic T cell response to a model of acute viral infection","volume":"89","author":"DeWitt","year":"2015","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.intimp.2023.111342_b0205","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","article-title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","volume":"80","author":"Deodhar","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0210","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.162.7.3830","article-title":"Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27","volume":"162","author":"Dulphy","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111342_b0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1399-0039.2002.600404.x","article-title":"Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen","volume":"60","author":"May","year":"2002","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/j.intimp.2023.111342_b0220","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2019-215442","article-title":"T cell receptor \u03b2 repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis","volume":"78","author":"Liu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.111342_b0225","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.111342_b0230","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.111342_b0235","article-title":"IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?","volume":"11","author":"Baeten","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111342_b0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1753425912470470","article-title":"Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation","volume":"19","author":"Silverpil","year":"2013","journal-title":"Innate Immun."},{"issue":"3","key":"10.1016\/j.intimp.2023.111342_b0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000484250","article-title":"The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis","volume":"85","author":"Dulic","year":"2018","journal-title":"Pathobiology"},{"key":"10.1016\/j.intimp.2023.111342_b0250","doi-asserted-by":"crossref","first-page":"1017938","DOI":"10.1155\/2021\/1017938","article-title":"Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-\u03b1 Therapy and Their Correlations with Treatment Outcomes","volume":"2021","author":"Chen","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2023.111342_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.738316","article-title":"Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111342_b0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1302\/2046-3758.122.BJR-2022-0195.R1","article-title":"Cytokines and regulatory T cells in ankylosing spondylitis","volume":"12","author":"Liao","year":"2023","journal-title":"Bone Joint Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.111342_b0265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13075-015-0655-9","article-title":"Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing","volume":"17","author":"Thapa","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.111342_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102574","article-title":"Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4(+) and CD8(+) T-cell clusters in systemic sclerosis","volume":"117","author":"Servaas","year":"2021","journal-title":"J. Autoimmun."},{"issue":"24","key":"10.1016\/j.intimp.2023.111342_b0275","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1111\/jcmm.17623","article-title":"Application of T-cell receptor repertoire as a novel monitor in dynamic tracking and assessment: A cohort-study based on RA patients","volume":"26","author":"Yang","year":"2022","journal-title":"J. Cell Mol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:16:12Z","timestamp":1761588972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923016697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":55,"alternative-id":["S1567576923016697"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111342","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of T-cell receptor repertoire in patients with ankylosing spondylitis after biologic therapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111342"}}